U.S., Feb. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07416110) titled 'Phase IIIb Clinical Trial to Evaluate Lot-to-lot Consistency of Sinovac Rabies Vaccine' on Feb. 10.
Brief Summary: To evaluate immunogenicity consistency between three consecutive batches of commercial-scale productions for Sinovac Rabies vaccine
Study Start Date: March 04
Study Type: INTERVENTIONAL
Condition:
Rabies (Healthy Volunteers)
Intervention:
BIOLOGICAL: Sinovac rabies vaccine
Three batchs of Rabies Vaccine (Serum-free Vero Cell), Freeze-dried using five doses of PEP schedules
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Sinovac Biotech Co., Ltd
Published by HT Digital Content Services with permission from Heal...